Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496236 · ClinicalTrials.gov registry record · Phase 1
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
A Phase 1 study, sponsored by GenVec.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00496236: Completed Phase 1 study, sponsored by GenVec.
NCT00496236 is a Phase 1 study that has completed, run by GenVec. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496236, a Phase 1 study, has completed, sponsored by GenVec.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
This study is looking at the safety and tolerability of TNFeradeä Biologic combined with conventional once daily radiation therapy in elderly or frail patients with new onset locally advanced head and neck tumors.
Interventions
- DRUG TNFerade biologic
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00496236 record still lists
NCT00496236 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which TNFerade biologic is the first listed.
NCT00496236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00496236 about?
NCT00496236 is a clinical study titled "Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer". This study is looking at the safety and tolerability of TNFeradeä Biologic combined with conventional once daily radiation therapy in elderly or frail patients with new onset locally advanced head and neck tumors.
What is the current status of trial NCT00496236?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00496236?
The interventions under investigation include: TNFerade biologic (DRUG).
Who is sponsoring clinical trial NCT00496236?
This trial is sponsored by GenVec, which has 7 total clinical trials registered on ClinicalTrials.gov.